Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Understand the rationale behind cash back rewards on credit cards. Learn how to take advantage of these offers.
26,130 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
As 2026 unfolds, retirees weigh early access to Social Security against lifetime income. Early claiming can reduce mo...
A surge in 2024 five-percent CDs is quietly lifting Medicare premiums in 2026 through IRMAA, due to income reported t...
A $1.5 million portfolio can still fund a solid retirement in 2026, but success hinges on disciplined withdrawals, ta...
A single moment on camera can reveal how perception, risk, and money collide. This piece examines what the mark zucke...
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
A 53-year-old investor says i’m with $1.5 million and dreams of Carmel and a sports car. The reality check shows high...
Two Roundhill ETFs harness a 0DTE covered call strategy to deliver regular Friday payouts, but investors should weigh...
When the Fed paused, a 72-year-old retired investor moved money from stocks to Treasuries for stability. The plan loo...
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...
SCPQ rose sharply as SpaceX slipped to fresh lows, underscoring daily-reset risks in leveraged inverse ETFs and the m...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...